» Articles » PMID: 31275242

Role of C-Kit in Myocardial Regeneration and Aging

Abstract

c-Kit, a type III receptor tyrosine kinase (RTK), is involved in multiple intracellular signaling whereby it is mainly considered a stem cell factor receptor, which participates in vital functions of the mammalian body, including the human. Furthermore, c-kit is a necessary yet not sufficient marker to detect and isolate several types of tissue-specific adult stem cells. Accordingly, c-kit was initially used as a marker to identify and enrich for adult cardiac stem/progenitor cells (CSCs) that were proven to be clonogenic, self-renewing and multipotent, being able to differentiate into cardiomyocytes, endothelial cells and smooth muscle cells as well as after myocardial injury. Afterwards it was demonstrated that c-kit expression labels a heterogenous cardiac cell population, which is mainly composed by endothelial cells while only a very small fraction represents CSCs. Furthermore, c-kit as a signaling molecule is expressed at different levels in this heterogenous c-kit labeled cardiac cell pool, whereby c-kit low expressers are enriched for CSCs while c-kit high expressers are endothelial and mast cells. This heterogeneity in cell composition and expression levels has been neglected in recent genetic fate map studies focusing on c-kit, which have claimed that c-kit identifies cells with robust endothelial differentiation potential but with minimal if not negligible myogenic commitment potential. However, modification of c-kit gene for Cre Recombinase expression in these Cre/Lox genetic fate map mouse models produced a detrimental c-kit haploinsufficiency that prevents efficient labeling of true CSCs on one hand while affecting the regenerative potential of these cells on the other. Interestingly, c-kit haploinsufficiency in c-kit-deficient mice causes a worsening myocardial repair after injury and accelerates cardiac aging. Therefore, these studies have further demonstrated that adult c-kit-labeled CSCs are robustly myogenic and that the adult myocardium relies on c-kit expression to regenerate after injury and to counteract aging effects on cardiac structure and function.

Citing Articles

Receptor tyrosine kinases: biological functions and anticancer targeted therapy.

Zhang N, Li Y MedComm (2020). 2023; 4(6):e446.

PMID: 38077251 PMC: 10701465. DOI: 10.1002/mco2.446.


Urokinase-Type Plasminogen Activator Receptor Regulates Prosurvival and Angiogenic Properties of Cardiac Mesenchymal Stromal Cells.

Dergilev K, Tsokolaeva Z, Goltseva Y, Beloglazova I, Ratner E, Parfyonova Y Int J Mol Sci. 2023; 24(21).

PMID: 37958542 PMC: 10650341. DOI: 10.3390/ijms242115554.


C-kit cells in the human left atrial appendage.

Schwarzkopf L, Buttner P, Scholtyssek K, Schroter T, Hiller R, Hindricks G Heliyon. 2023; 9(11):e21268.

PMID: 37954289 PMC: 10637945. DOI: 10.1016/j.heliyon.2023.e21268.


Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications.

da Silva F, de Azevedo Jr J, Ralph A, de Jesus Viana Pinheiro J, Freitas V, Calcagno D Front Oncol. 2023; 13:1191218.

PMID: 37476370 PMC: 10354556. DOI: 10.3389/fonc.2023.1191218.


Athletes' Mesenchymal Stem Cells Could Be the Best Choice for Cell Therapy in Omicron-Infected Patients.

Saheli M, Khoramipour K, Vosough M, Piryaei A, Rahmati M, Suzuki K Cells. 2022; 11(12).

PMID: 35741055 PMC: 9221912. DOI: 10.3390/cells11121926.


References
1.
Nagy A . Cre recombinase: the universal reagent for genome tailoring. Genesis. 2000; 26(2):99-109. View

2.
Sellers S, Tisdale J, Agricola B, Metzger M, Donahue R, Dunbar C . The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells. Blood. 2001; 97(6):1888-91. DOI: 10.1182/blood.v97.6.1888. View

3.
Longley B, Reguera M, Ma Y . Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk Res. 2001; 25(7):571-6. DOI: 10.1016/s0145-2126(01)00028-5. View

4.
Dolci S, Pellegrini M, Di Agostino S, Geremia R, Rossi P . Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor. J Biol Chem. 2001; 276(43):40225-33. DOI: 10.1074/jbc.M105143200. View

5.
Kondo M, Wagers A, Manz M, Prohaska S, Scherer D, Beilhack G . Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003; 21:759-806. DOI: 10.1146/annurev.immunol.21.120601.141007. View